Special Instructions 011 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002

Closed Special Notice Posted

This opportunity was awarded. See its 8 award notices in the notice history.

Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Washington DC 20201 USA

Notice details come from SAM.gov. Updated .

About this opportunity

This Special Notice from the Department of Health and Human Services' Biomedical Advanced Research and Development Authority adds "Area of Interest #5: ReDIRECT (Repurposing Drugs In Response to Chemical Threats)" to its existing Easy Broad Agency Announcement soliciting proposals for medical countermeasures against chemical threats. BARDA seeks to identify already approved or late-stage drugs that can be repurposed to treat exposure symptoms from chemicals including cyanide, opioids, nerve agents, chlorine, and sulfur mustard.

The objective is to repurpose existing drugs to treat effects of pulmonary, vesicant, blood, or metabolic agents or nerve agents and organophosphates. Proposals should identify drugs with a known safety profile that are safe and effective for all populations. Abstract submissions will be accepted through January 31, 2021 for awards under $750,000 in total government funding. Interested parties should contact the program manager in advance to understand objectives for this new Area of Interest. Proposals must involve drugs manufactured in the United States, and the submission and review process will follow the existing Easy Broad Agency Announcement.

Notice text

2 versions

Update #2 · Latest ·

Under these Special Instructions 011, BARDA is now accepting abstract submissions for "Area of Interest #5: ReDIRECT (Repurposing Drugs In Response to Chemical Threats)" as part of its EZ-BAA (BAA-20-100-SOL-0002).

Update #1 ·

Under these Special Instructions 011, BARDA is adding "Area of Interest #5: ReDIRECT (Repurposing Drugs In Response to Chemical Threats)" as part of its EZ-BAA (BAA-20-100-SOL-0002).

Files

File Type Posted
DRIVe EZ-BAA - Special Instructions 011.pdf PDF

Notice history

Notice Type Posted
Special Instructions 019 Issuance for Easy Broad Agency Announcement (EZ-BAA) Latest special notice Special Notice
Special Instructions 018 Issuance for Easy Broad Agency Announcement (EZ-BAA) Special Notice
Special Instructions 017 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002 Special Notice
Special Instructions 016 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002 Special Notice
Special Instructions 015 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002 Special Notice
Special Instructions 014 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002 Special Notice
Special Instructions 013 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002 Special Notice
Esperovax Award Notice
Siemens Healthcare Diagnostics, Inc. Award Notice
Nanomix, Inc. Award Notice
This notice Special Notice
Special Instructions 010 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002 Special Notice
Special Instructions 009 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002 Special Notice
Special Instructions 008 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002 Special Notice
Special Instructions 007 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002 Special Notice
Show 5 more

15 notices listed here. See the rest on GovTribe.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors